<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="liv14222-tbl-0001" xml:lang="en" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Viral hepatitis service coverage and impact targets</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1">Target area</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Baseline 2015</th>
    <th align="left" valign="top" rowspan="1" colspan="1">2020 Target</th>
    <th align="left" valign="top" rowspan="1" colspan="1">2030 Target</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" colspan="4" rowspan="1">Service coverage targets</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hepatitis B virus vaccination: childhood vaccine coverage (third dose coverage)</td>
    <td align="left" rowspan="1" colspan="1">82% of infants</td>
    <td align="left" rowspan="1" colspan="1">90%</td>
    <td align="left" rowspan="1" colspan="1">90%</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Prevention of hepatitis B virus mother‐to‐child transmission: hepatitis B virus birth‐dose coverage or other approach to prevent mother‐to‐child transmission</td>
    <td align="left" rowspan="1" colspan="1">38%</td>
    <td align="left" rowspan="1" colspan="1">50%</td>
    <td align="left" rowspan="1" colspan="1">90%</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood safety: donations screened with quality assurance</td>
    <td align="left" rowspan="1" colspan="1">89%</td>
    <td align="left" rowspan="1" colspan="1">95%</td>
    <td align="left" rowspan="1" colspan="1">100%</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Injection safety: use of engineered devices</td>
    <td align="left" rowspan="1" colspan="1">5%</td>
    <td align="left" rowspan="1" colspan="1">50%</td>
    <td align="left" rowspan="1" colspan="1">90%</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sterile needle/syringe set distributed per person per year for people who inject drugs</td>
    <td align="left" rowspan="1" colspan="1">20</td>
    <td align="left" rowspan="1" colspan="1">200</td>
    <td align="left" rowspan="1" colspan="1">300</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Viral hepatitis B and C diagnosis (coverage %)</td>
    <td align="left" rowspan="1" colspan="1">&lt;5% of chronic hepatitis infections diagnosed</td>
    <td align="left" rowspan="1" colspan="1">30%</td>
    <td align="left" rowspan="1" colspan="1">90%</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Viral hepatitis B and C treatment (coverage %)</td>
    <td align="left" rowspan="1" colspan="1">&lt;1% receiving treatment</td>
    <td align="left" rowspan="1" colspan="1">3 million</td>
    <td align="left" rowspan="1" colspan="1">80% eligible treated</td>
   </tr>
   <tr>
    <td align="left" colspan="4" rowspan="1">Impact targets</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Incidence: new cases of viral hepatitis B and C infections</td>
    <td align="left" rowspan="1" colspan="1">Between 6 and 10 million infections are reduced to 0.9 million infections by 2030 (95% declined in hepatitis B virus infections, 80% decline in hepatitis C virus infections)</td>
    <td align="left" rowspan="1" colspan="1">30% reduction (equivalent to 1% prevalence of HBsAg among children)</td>
    <td align="left" rowspan="1" colspan="1">90% reduction (equivalent to 0.1% prevalence of HBsAg among children)</td>
   </tr>
   <tr>
    <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Mortality: viral hepatitis B and C deaths</td>
    <td align="left" rowspan="1" colspan="1">1.4 million deaths reduced to less than 500 000 by 2030 (65% for both viral hepatitis B and C)</td>
    <td align="left" rowspan="1" colspan="1">10% reduction</td>
    <td align="left" rowspan="1" colspan="1">65% reduction</td>
   </tr>
  </tbody>
 </table>
 <attrib>Source: Global Health Sector Strategy on Viral Hepatitis, 2016‐2021.
  <xref rid="liv14222-bib-0018" ref-type="ref">18</xref>
 </attrib>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
